Various nature products have been verified to enhance the antitumor efficacy of paclitaxel and mitigate its toxic and adverse reactions. However, the co-delivery of paclitaxel and natural products remains a significant challenge in the pharmaceutical field. In recent years, strategies such as drug self-assembly, drug carriers, and new formulation forms have been employed to concurrently deliver natural products and paclitaxel to tumor sites, aiming to exert their synergistic effects, thereby elevating antitumor activity of paclitaxel and circumventing drug resistance. This article systematically reviews relevant literature, focusing on the design strategies, release characteristics, and therapeutic effects of co-delivery systems, with the aim of providing insights and references for antitumor research combining paclitaxel and natural products.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |